The USP is actively working on several general chapters that are pertinent to nuclear medicine. These activities include the revision of General Chapter <821> Radioactivity, as well as the development of two new general chapters. The details of these changes are described below. Drafts of the affected General Chapters will appear in an upcoming issue of the Pharmacopeial Forum (PF) 41(5) [Sep.–Oct. 2015].
Visit the USP Key Issues page which provides information about the new chapters.
Logon or register for free access to the PF.
Public comments on these General Chapters will be accepted until November 30, 2015.
USP encourages the public to comment on these General Chapters especially from all members of the nuclear medicine and PET communities, including drug manufacturers, professional associations, and regulatory agencies.